Pawel Fludzinski
Directeur Général chez AmideBio LLC
Profil
Pawel Fludzinski is currently the President, Chief Executive Officer & Director at AmideBio LLC.
He previously worked as a Director at Standard BioTools, Inc. Fludzinski holds a doctorate degree from the University of Rochester and an undergraduate degree from Rensselaer Polytechnic Institute.
Postes actifs de Pawel Fludzinski
Sociétés | Poste | Début |
---|---|---|
AmideBio LLC
AmideBio LLC BiotechnologyHealth Technology AmideBio LLC operates as a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. Its products include amyloid peptides, amyloid kits & buffers, brazzeins, toxins and knottins. The company was founded by Mikhail Plam and Michael H. B. Stowell and is headquartered in Louisville, CO. | Directeur Général | 16/05/2018 |
Anciens postes connus de Pawel Fludzinski
Sociétés | Poste | Fin |
---|---|---|
STANDARD BIOTOOLS INC. | Directeur/Membre du Conseil | - |
Formation de Pawel Fludzinski
Rensselaer Polytechnic Institute | Undergraduate Degree |
Rochester Christian University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
STANDARD BIOTOOLS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
AmideBio LLC
AmideBio LLC BiotechnologyHealth Technology AmideBio LLC operates as a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. Its products include amyloid peptides, amyloid kits & buffers, brazzeins, toxins and knottins. The company was founded by Mikhail Plam and Michael H. B. Stowell and is headquartered in Louisville, CO. | Health Technology |